Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 USD | +0.85% | +7.88% | +16.34% |
05-02 | Transcript : Lexicon Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (LXRX) LEXICON PHARMACEUTICALS Posts Q1 Revenue $1.1M, vs. Street Est of $1.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.34% | 436M | |
+4.09% | 106B | |
+7.02% | 23.47B | |
-14.47% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.19% | 16.78B | |
+6.65% | 14.41B | |
+35.74% | 12.86B | |
+317.30% | 8.78B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals Q4 Net Loss Widens, Revenue Rises; to Resubmit NDA for Sotagliflozin; Shares Jump